Partnering opportunities in CHILD study

AllerGen continues to seek new partnering opportunities for the Canadian Healthy Infant Longitudinal Development study.

Several representatives from AllerGen and the Canadian Institutes of Health Research (CIHR) met in Toronto on Nov. 24, 2006, to discuss the development of the study and CIHR's commitment to the project.

"This collaborative initiative will bring together experts from AllerGen's research programme and the public and private sectors," says AllerGen Scientific Director Dr. Judah Denburg.

CHILD proposes to collect data on multiple risk factors for allergy and asthma, including indoor/outdoor environmental exposures, infections, nutrition, and immunologic responses and their interactions with genetic and host factors.

"The impacts of the CHILD study will be enduring and far-reaching. Outcomes from a study of this magnitude will inform the diagnosis, treatment and policy of allergic and related immune disease," Dr. Denburg says. "It will be a Canadian first in allergic disease research."